Medication
Compounded semaglutide is prepared by licensed compounding pharmacies (503A or 503B) for individual patients. Not FDA-approved as a finished drug. April 2026 FDA guidance tightened advertising and prescribing rules for compounded GLP-1 products. Pricing in patient-direct telehealth typically ranges $199–$449/month.
| Generic name | semaglutide |
| Brand manufacturer | 503A and 503B compounding pharmacies |
| FDA indication | Compounded — not FDA-approved as a finished drug |
| FDA approval year | N/A (compounded) |
| Form | Subcutaneous injection (multi-dose vial + syringe) |
| Schedule | Once weekly |
| List price (cash) | $199/month |
For drug-class comparisons, see our medication-comparison hub:
Coverage varies significantly by carrier and employer plan. See our insurance hub for plan-specific guidance:
Compounded Semaglutide is the brand name for semaglutide, manufactured by 503A and 503B compounding pharmacies. Compounded semaglutide is prepared by licensed compounding pharmacies (503A or 503B) for individual patients. Not FDA-approved as a finished drug. April 2026 FDA guidance tightened advertising and pre
Compounded Semaglutide list price is approximately $199/month. Insurance may cover it with prior authorization for FDA-approved indications.
Not FDA-approved (compounded). Indication: Compounded — not FDA-approved as a finished drug.
Doses available: Custom titration: typical 0.25 mg → 2.4 mg weekly. Schedule: Once weekly. Always follow your prescribing clinician's titration plan.
See our medication comparisons hub for head-to-head pages on Wegovy vs Zepbound, Ozempic vs Wegovy, and semaglutide vs tirzepatide.
Note: This page is an editorial overview, not medical advice. Always consult a licensed clinician about whether Compounded Semaglutide is appropriate for you.